1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
Primary endpoint(s) modified
Also in this update: Enrollment reopened; Enrollment increased: 9 → 72 participants
GERCOR - Multidisciplinary Oncology Cooperative GroupNot applicable NCT06275737 Registry history of NCT06275737 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 2 | 14 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT03828227 | QoL in mCRC Elderly Patients Receiving First-line Therapy Based on Simplified Geriatric… | Elderly Patients | Active, Not Recruiting | 2025-07-18 |
| Phase 2 | ||||
| NCT06059495 | DEWI: Watch-and-Wait With Dostarlimab in Localized dMMR/MSI-H Gastric/GEJ Adenocarcinoma… | Adenocarcinoma - GEJ | Recruiting | 2026-08-26 |
| NCT06253611 | First-line EXL01 With Nivolumab and FOLFOX for PD-L1 CPS ≥5 Metastatic Gastric Cancer | Gastric Cancer | Recruiting | 2025-09-22 |
| NCT04268121 | Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive… | Neuroendocrine Carcinoma | Recruiting | 2025-07-23 |
| NCT05310643 | Nivolumab and Ipilimumab in Anti-PD1-Resistant dMMR/MSI mCRC | Metastatic Colorectal Cancer | Recruiting | 2025-07-01 |
| NCT04166604 | LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy | Metastatic Colorectal Cancer | Active, Not Recruiting | 2025-08-19 |
| NCT03806309 | OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in… | Pancreatic Ductal Adenocarcinoma | Active, Not Recruiting | 2025-07-25 |
| NCT04348045 | Maintenance With Olaparib or Selumetinib + Durvaluma for m-PDAC Guided by BRCAness and… | Metastatic Pancreatic Adenocarcinoma | Active, Not Recruiting | 2025-07-25 |
| NCT03350126 | iRECIST Evaluation's Relevance for DCR in MMR/MSI Metastatic Colorectal Cancer Patients… | Metastatic Cancer Colorectal | Active, Not Recruiting | 2025-07-23 |
| NCT03704480 | Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy. | Advanced Biliary Tract Carcinoma | Active, Not Recruiting | 2025-07-23 |
| NCT07071844 | BETWEEN: Biweekly Bevacizumab + Trifluridine/Tipiracil to Reduce Grade 3-4 Neutropenia in… | Metastatic Colorectal Cancer | Not Yet Recruiting | 2025-07-17 |
| NCT07028424 | PANORAMIX : Optimizing 1st-line NALIRIFOX and Exploring Microbiota's Role in 2nd Line… | PDAC - Pancreatic Ductal Adenocarcinoma | Not Yet Recruiting | 2025-07-01 |
| NCT04006262 | Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for… | Localized Oesogastric Adenocarcimona | Active, Not Recruiting | 2025-06-15 |
| NCT04730544 | Two Combination Treatment Regimens of Nivolumab and Ipilimumab in Patients With dMMR and… | Colorectal Cancer Metastatic | Active, Not Recruiting | 2025-06-13 |
| NCT06646445 | Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon… | Colon Cancer | Not Yet Recruiting | 2025-06-13 |
| Not applicable | ||||
| NCT06275737 | POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for… | Pancreatic Ductal Adenocarcinoma | Recruiting | 2026-09-17 |
| NCT05850130 | Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Gastro-intestinal Cancer… | Colorectal Cancer | Recruiting | 2026-09-11 |
| NCT02979483 | Management of Symptomatic Advanced Pancreatic Adenocarcinoma | Pancreas | Active, Not Recruiting | 2025-06-13 |
| Not specified | ||||
| NCT04935853 | Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct… | Biliary Tract Cancer | Recruiting | 2025-07-23 |
| NCT05787197 | ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases | Metastatic Colorectal Cancer | Recruiting | 2025-07-23 |
| NCT05776342 | Prognostic and Predictive Markers of Treatment Response in Patients With PAC. | Pancreatic Adenocarcinoma | Recruiting | 2025-03-25 |
Colorectal Cancer (9) · Pancreatic Cancer (6) · Gastric Cancer (3) · Cholangiocarcinoma (2) · Esophageal Cancer (2) · Liver Cancer (1)